Danset 4Mg/2ml Intramacular/Intravenous 3 Ampoules

o For prevention of Highly Emetogenic Chemotherapy Induced Nausea and Vomiting: Initial IV dose of 8 mg (max 16 mg) infused over 15 minutes, given at least 30 minutes prior to chemotherapy. o It is not indicated for the treatment of children less than 4 years old. Key Benefits: • DANSET Ampoule is a 5-HT3 receptor antagonist indicated for the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy • Active ingredient: Ondansetron 4mg/2ml • Indication: o For the prevention of nausea and vomiting • Dosage and administration: o It should be described by physician. o For prevention of Highly Emetogenic Chemotherapy Induced Nausea and Vomiting: Initial IV dose of 8 mg (max 16 mg) infused over 15 minutes, given at least 30 minutes prior to chemotherapy. o It is not indicated for the treatment of children less than 4 years old